Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults. Reply.
Journal: The New England journal of medicine
Published: August 12, 2026
Immune correlates analysis in NextCOVE trial for a next-generation mRNA-1283 COVID-19 vaccine.
Journal: Human vaccines & immunotherapeutics
Published: June 01, 2026
Safety and durability of influenza and SARS-CoV-2 antibody responses through 6 months after a single dose of mRNA-1083, a multicomponent influenza and COVID-19 vaccine, in adults ≥50 years.
Journal: Human vaccines & immunotherapeutics
Published: May 29, 2026
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults.
Journal: The New England journal of medicine
Published: May 06, 2026
Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies.
Journal: The Journal of infectious diseases
Published: November 06, 2025
Strong-field induced ionization and dissociation of cis- and trans-1,2-dichloroethylene: Cl+ and HCl+ fragments.
Journal: Physical chemistry chemical physics : PCCP
Published: October 22, 2025
Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants.
Journal: Vaccine
Published: July 25, 2025
Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 13, 2025
Immunogenicity of JN.1- and KP.2-Encoding mRNA COVID-19 Vaccines Against JN.1 Subvariants in Adult Participants.
Journal: Open forum infectious diseases
Published: June 10, 2025
Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18-59 Years.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 16, 2025
RNA helicase maheshvara interacts with TDP-43 and exacerbates neurodegeneration in Drosophila model of amyotrophic lateral sclerosis.
Journal: Neurobiology of disease
Published: April 03, 2025
Last Updated: 09/26/2026